FAIM
AVEO

Financial Advocates Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Financial Advocates Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,500
Closed -$24K – 473
2018
Q4 		$24K Buy
+1,500
New +$33K ﹤0.01% 420

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Financial Advocates Investment Management's AVEO Position: Q1 2019 in Review

Financial Advocates Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 1,500 shares — an estimated $24K sold.

Financial Advocates Investment Management first reported a position in AVEO in Q4 2018 and held it in 1 quarter. The position peaked at $24K in Q4 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

  • Financial Advocates Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Financial Advocates Investment Management sold 1,500 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $24K.
  • Financial Advocates Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 1 quarter.
  • Financial Advocates Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $24K in Q4 2018.
  • 83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on Financial Advocates Investment Management's 13F filing for Q1 2019, filed 16 May 2019.